Crossmark

Did ATOMIC really improve on the standard of care for mismatch repair-deficient colon cancer?

Published Online: 2026-04-23

Authors

Benitez-Fuentes, Javier-David

Karikios, Deme

Gyawali, Bishal https://orcid.org/0000-0001-7444-8594
License Information

Text and Data Mining valid from 2026-04-23

Version of Record valid from 2026-04-23
More Information

Article History

First Online: 23 April 2026

Competing interests

: J.-D.B.-F. declares no competing interests. B.G. has acted as a consultant of Vivio Health. D.K. has acted as an advisor of Lutris, MSD, Roche and Takeda, and has received speaker’s fees from Abbvie and AstraZeneca.

Document is current